Latest Cellular differentiation Stories
Although pharmaceutical companies recognize that promising new drugs that are toxic to adult stem cells are likely to fail, the industry has been unable to do much about this problem, which is
HLA “superdonor” cell lines potentially provide a beneficial genetic match to a large numbers of patients in the United States. Madison, WI (PRWEB) February
Neil Dymott attorneys Jonathan Ehtessabian and Clark Hudson receive summary judgment in Innovative Stem Cell Study case San Diego, California (PRWEB) January
SAN BRUNO, Calif. and MADISON, Wis., Jan.
In a new “proof of concept” experiment, scientists have managed to edit the genome of sperm-producing adult stem cells, creating a break in the DNA strands of a mutant gene in mouse cells then repairing it by replacing flawed segments with corrected ones.
David Hodl to lead Commercialization of the SynGen Cell Processing and Laboratory Instrumentation Product Lines SACRAMENTO, Calif., Nov.
Understanding the self-replication mechanisms is critical for improving stem cell therapies for blood-related diseases and cancers.
GERMANTOWN, Md., Nov.
By combining efforts and innovations, Wyss Institute scientists develop synthetic gene controls for programmable diagnostics and biosensors, delivered out of the lab on pocket-sized slips of paper.
- A political dynamiter.